Skip to main content
Erschienen in: Journal of Cancer Survivorship 3/2014

01.09.2014

Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study

verfasst von: K. Wasilewski-Masker, K. D. Seidel, W. Leisenring, A. C. Mertens, M. Shnorhavorian, C. W. Ritenour, M. Stovall, D. M. Green, C. A. Sklar, G. T. Armstrong, L. L. Robison, L. R. Meacham

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to assess the prevalence of male infertility and treatment-related risk factors in childhood cancer survivors.

Methods

Within the Childhood Cancer Survivor Study, 1,622 survivors and 274 siblings completed the Male Health Questionnaire. The analysis was restricted to survivors (938/1,622; 57.8 %) and siblings (174/274; 63.5 %) who tried to become pregnant. Relative risks (RR) and 95 % confidence intervals (CI) for the prevalence of self-reported infertility were calculated using generalized linear models for demographic variables and treatment-related factors to account for correlation among survivors and siblings of the same family. All statistical tests were two-sided.

Results

Among those who provided self-report data, the prevalence of infertility was 46.0 % in survivors versus 17.5 % in siblings (RR = 2.64, 95 % CI 1.88–3.70, p < 0.001). Of survivors who met the definition for infertility, 37 % had reported at least one pregnancy with a female partner that resulted in a live birth. In a multivariable analysis, risk factors for infertility included an alkylating agent dose (AAD) score ≥3 (RR = 2.13, 95 % CI 1.69–2.68 for AAD ≥3 versus AAD <3), surgical excision of any organ of the genital tract (RR = 1.63, 95 % CI 1.20–2.21), testicular radiation ≥4 Gy (RR = 1.99, 95 % CI 1.52–2.61), and exposure to bleomycin (RR = 1.55, 95 % CI 1.20–2.01).

Conclusion

Many survivors who experience infertility father their own children, suggesting episodes of both fertility and infertility. This and the novel association of infertility with bleomycin warrant further investigation.

Implications for Cancer Survivors

Though infertility is common, male survivors reporting infertility often father their own children. Bleomycin may pose some fertility risk.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Byrne J, Fears TR, Mills JL, Zeltzer LK, Sklar C, Meadows AT, et al. Fertility of long-term male survivors of acute lymphoblastic leukemia diagnosed during childhood. Pediatr Blood Cancer. 2004;42(4):364–72. doi:10.1002/pbc.10449.CrossRefPubMed Byrne J, Fears TR, Mills JL, Zeltzer LK, Sklar C, Meadows AT, et al. Fertility of long-term male survivors of acute lymphoblastic leukemia diagnosed during childhood. Pediatr Blood Cancer. 2004;42(4):364–72. doi:10.​1002/​pbc.​10449.CrossRefPubMed
5.
Zurück zum Zitat Magelssen H, Melve KK, Skjaerven R, Fossa SD. Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood. Hum Reprod. 2008;23(1):178–86. doi:10.1093/humrep/dem362.CrossRefPubMed Magelssen H, Melve KK, Skjaerven R, Fossa SD. Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood. Hum Reprod. 2008;23(1):178–86. doi:10.​1093/​humrep/​dem362.CrossRefPubMed
9.
Zurück zum Zitat Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38(4):229–39.CrossRefPubMed Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38(4):229–39.CrossRefPubMed
10.
Zurück zum Zitat Tucker MA, Meadows AT, Boice Jr JD, Stovall M, Oberlin O, Stone BJ, et al. Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst. 1987;78(3):459–64.PubMed Tucker MA, Meadows AT, Boice Jr JD, Stovall M, Oberlin O, Stone BJ, et al. Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst. 1987;78(3):459–64.PubMed
13.
Zurück zum Zitat Stovall M, Weathers R, Kasper C, Smith SA, Travis L, Ron E, et al. Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies. Radiat Res. 2006;166(1 Pt 2):141–57. doi:10.1667/RR3525.1.CrossRefPubMed Stovall M, Weathers R, Kasper C, Smith SA, Travis L, Ron E, et al. Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies. Radiat Res. 2006;166(1 Pt 2):141–57. doi:10.​1667/​RR3525.​1.CrossRefPubMed
14.
Zurück zum Zitat Packer RJ, Gurney JG, Punyko JA, Donaldson SS, Inskip PD, Stovall M, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol. 2003;21(17):3255–61. doi:10.1200/JCO.2003.01.202.CrossRefPubMed Packer RJ, Gurney JG, Punyko JA, Donaldson SS, Inskip PD, Stovall M, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol. 2003;21(17):3255–61. doi:10.​1200/​JCO.​2003.​01.​202.CrossRefPubMed
15.
Zurück zum Zitat Zeger SL, Liang KY. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.CrossRef Zeger SL, Liang KY. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.CrossRef
16.
Zurück zum Zitat Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.CrossRefPubMed Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.CrossRefPubMed
20.
Zurück zum Zitat Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat. 2005;23(25):1–160. Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat. 2005;23(25):1–160.
21.
Zurück zum Zitat Slama R, Hansen OK, Ducot B, Bohet A, Sorensen D, Giorgis Allemand L, et al. Estimation of the frequency of involuntary infertility on a nation-wide basis. Hum Reprod. 2012;27(5):1489–98. doi:10.1093/humrep/des070.CrossRefPubMed Slama R, Hansen OK, Ducot B, Bohet A, Sorensen D, Giorgis Allemand L, et al. Estimation of the frequency of involuntary infertility on a nation-wide basis. Hum Reprod. 2012;27(5):1489–98. doi:10.​1093/​humrep/​des070.CrossRefPubMed
24.
Zurück zum Zitat Rowley MJ, Leach DR, Warner GA, Heller CG. Effect of graded doses of ionizing radiation on the human testis. Radiat Res. 1974;59(3):665–78.CrossRefPubMed Rowley MJ, Leach DR, Warner GA, Heller CG. Effect of graded doses of ionizing radiation on the human testis. Radiat Res. 1974;59(3):665–78.CrossRefPubMed
26.
Zurück zum Zitat Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin N Am. 1998;27(4):927–43.CrossRef Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin N Am. 1998;27(4):927–43.CrossRef
27.
Zurück zum Zitat Jaffe N, Sullivan MP, Ried H, Boren H, Marshall R, Meistrich M, et al. Male reproductive function in long-term survivors of childhood cancer. Med Pediatr Oncol. 1988;16(4):241–7.CrossRefPubMed Jaffe N, Sullivan MP, Ried H, Boren H, Marshall R, Meistrich M, et al. Male reproductive function in long-term survivors of childhood cancer. Med Pediatr Oncol. 1988;16(4):241–7.CrossRefPubMed
31.
Zurück zum Zitat Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G. Gonadal toxicity after combination chemotherapy for Hodgkin’s disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol. 1985;21(5):601–5.CrossRefPubMed Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G. Gonadal toxicity after combination chemotherapy for Hodgkin’s disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol. 1985;21(5):601–5.CrossRefPubMed
33.
Zurück zum Zitat van der Kaaij MA, Heutte N, Le Stang N, Raemaekers JM, Simons AH, Carde P, et al. Gonadal function in males after chemotherapy for early-stage Hodgkin’s lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol. 2007;25(19):2825–32. doi:10.1200/JCO.2006.10.2020.CrossRefPubMed van der Kaaij MA, Heutte N, Le Stang N, Raemaekers JM, Simons AH, Carde P, et al. Gonadal function in males after chemotherapy for early-stage Hodgkin’s lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol. 2007;25(19):2825–32. doi:10.​1200/​JCO.​2006.​10.​2020.CrossRefPubMed
34.
Zurück zum Zitat Rueffer U, Breuer K, Josting A, Lathan B, Sieber M, Manzke O, et al. Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Ann Oncol. 2001;12(9):1307–11.CrossRefPubMed Rueffer U, Breuer K, Josting A, Lathan B, Sieber M, Manzke O, et al. Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Ann Oncol. 2001;12(9):1307–11.CrossRefPubMed
35.
Zurück zum Zitat Byrne J, Fears TR, Mills JL, Zeltzer LK, Sklar C, Nicholson HS, et al. Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2004;42(7):589–97. doi:10.1002/pbc.20033.CrossRefPubMed Byrne J, Fears TR, Mills JL, Zeltzer LK, Sklar C, Nicholson HS, et al. Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2004;42(7):589–97. doi:10.​1002/​pbc.​20033.CrossRefPubMed
37.
Zurück zum Zitat Schmiegelow M, Lassen S, Poulsen HS, Schmiegelow K, Hertz H, Andersson AM, et al. Gonadal status in male survivors following childhood brain tumors. J Clin Endocrinol Metab. 2001;86(6):2446–52.PubMed Schmiegelow M, Lassen S, Poulsen HS, Schmiegelow K, Hertz H, Andersson AM, et al. Gonadal status in male survivors following childhood brain tumors. J Clin Endocrinol Metab. 2001;86(6):2446–52.PubMed
38.
Zurück zum Zitat Green DM, Nolan VG, Kawashima T, Stovall M, Donaldson SS, Srivastava D, et al. Decreased fertility among female childhood cancer survivors who received 22–27 Gy hypothalamic/pituitary irradiation: a report from the Childhood Cancer Survivor Study. Fertil Steril. 2011;95(6):1922–7. doi:10.1016/j.fertnstert.2011.02.002. Green DM, Nolan VG, Kawashima T, Stovall M, Donaldson SS, Srivastava D, et al. Decreased fertility among female childhood cancer survivors who received 22–27 Gy hypothalamic/pituitary irradiation: a report from the Childhood Cancer Survivor Study. Fertil Steril. 2011;95(6):1922–7. doi:10.​1016/​j.​fertnstert.​2011.​02.​002.
39.
Metadaten
Titel
Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study
verfasst von
K. Wasilewski-Masker
K. D. Seidel
W. Leisenring
A. C. Mertens
M. Shnorhavorian
C. W. Ritenour
M. Stovall
D. M. Green
C. A. Sklar
G. T. Armstrong
L. L. Robison
L. R. Meacham
Publikationsdatum
01.09.2014
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 3/2014
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-014-0354-6

Weitere Artikel der Ausgabe 3/2014

Journal of Cancer Survivorship 3/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.